2,4-dinitrobenzenesulfonic acid has been researched along with mesalamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cosenza, V; D'Argenio, G; Di Marzo, V; Scaglione, G; Sorrentini, I; Valenti, M | 1 |
Jeong, S; Jung, Y; Kim, D; Kim, W; Yang, Y; Yoo, JW | 1 |
Joshi, N; Mishra, N; Singh, A; Thakur, V | 1 |
3 other study(ies) available for 2,4-dinitrobenzenesulfonic acid and mesalamine
Article | Year |
---|---|
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
Topics: Adult; Aged; Amidohydrolases; Animals; Arachidonic Acids; Benzenesulfonates; Colitis; Colitis, Ulcerative; Colon; Disease Models, Animal; Drug Evaluation, Preclinical; Endocannabinoids; Female; Glycerides; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mesalamine; Mice; Mice, Inbred C57BL; Middle Aged; Peroxidase; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Serotonin; Specific Pathogen-Free Organisms; Trinitrobenzenesulfonic Acid | 2006 |
A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azo Compounds; Benzenesulfonates; Colitis; Colon; Disease Models, Animal; Male; Mesalamine; Metoclopramide; Prodrugs; Rats; Rats, Sprague-Dawley | 2019 |
Spray dried formulation of mesalamine embedded with probiotic biomass for the treatment of ulcerative colitis:
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzenesulfonates; Caco-2 Cells; Colitis, Ulcerative; Colon; Disease Models, Animal; Drug Carriers; Drug Combinations; Drug Compounding; Drug Liberation; Female; Humans; Lactobacillus acidophilus; Male; Mesalamine; Particle Size; Polymethacrylic Acids; Probiotics; Rats; Rats, Wistar | 2019 |